1.Gabbs, M, Leng, S, Devassy, JG, et al. (2015) Advances in our understanding of oxylipins derived from dietary PUFAs. Adv Nutr 6, 513–540.
2.Funk, CD (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294, 1871–1875.
3.Li, N, Liu, JY, Qiu, H, et al. (2011) Use of metabolomic profiling in the study of arachidonic acid metabolism in cardiovascular disease. Congest Heart Fail 17, 42–46.
4.Caligiuri, SPB, Parikh, M, Stamenkovic, A, et al. (2017) Dietary modulation of oxylipins in cardiovascular disease and aging. Am J Physiol Heart Circ Physiol 313, H903–H918.
5.Gu, X, Xu, J, Zhu, L, et al. (2016) Prostaglandin E2 reduces cardiac contractility via EP3 Receptor. Circ Heart Fail 9, e003291.
6.Elkhatali, S, El-Sherbeni, AA, Elshenawy, OH, et al. (2015) 19-Hydroxyeicosatetraenoic acid and isoniazid protect against angiotensin II-induced cardiac hypertrophy. Toxicol Appl Pharmacol 289, 550–559.
7.Alsaad, AM, Zordoky, BN, Tse, MM, et al. (2013) Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy. Drug Metab Rev 45, 173–195.
8.Dai, M, Wu, L, He, Z, et al. (2015) Epoxyeicosatrienoic acids regulate macrophage polarization and prevent LPS-induced cardiac dysfunction. J Cell Physiol 230, 2108–2119.
9.Maayah, ZH, El-Kadi, AO (2016) 5-, 12- and 15-Hydroxyeicosatetraenoic acids induce cellular hypertrophy in the human ventricular cardiomyocyte, RL-14 cell line, through MAPK- and NF-kappaB-dependent mechanism. Arch Toxicol 90, 359–373.
10.Endo, J, Sano, M, Isobe, Y, et al. (2014) 18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload-induced maladaptive cardiac remodeling. J Exp Med 211, 1673–1687.
11.Ye, D, Zhang, D, Oltman, C, et al. (2002) Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels. J Pharmacol Exp Ther 303, 768–776.
12.Hoffmann, P, Mentz, P, Blass, KE, et al. (1982) Influence of dietary linoleic acid on cardiac function and prostaglandin release and on the effects of isoprenaline in the isolated rat heart. J Cardiovasc Pharmacol 4, 714–720.
13.Tloti, MA, Moon, DG, Weston, LK, et al. (1991) Effect of 13-hydroxyoctadeca-9,11-dienoic acid (13-HODE) on thrombin induced platelet adherence to endothelial cells in vitro. Thromb Res 62, 305–317.
14.Viswanathan, S, Hammock, BD, Newman, JW, et al. (2003) Involvement of CYP 2C9 in mediating the proinflammatory effects of linoleic acid in vascular endothelial cells. J Am Coll Nutr 22, 502–510.
15.Willenberg, I, Rund, K, Rong, S, et al. (2016) Characterization of changes in plasma and tissue oxylipin levels in LPS and CLP induced murine sepsis. Inflamm Res 65, 133–142.
16.Pinto, AM, Sanders, TAB, Kendall, AC, et al. (2017) A comparison of heart rate variability, n-3 PUFA status and lipid mediator profile in age-and BMI-matched middle-aged vegans and omnivores. Br J Nutr 117, 669–685.
17.Balvers, MGJ, Verhoeckx, KCM, Bijlsma, S, et al. (2012) Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues. Metabolomics 8, 1130–1147.
18.Shearer, GC, Harris, WS, Pedersen, TL, et al. (2010) Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters. J Lipid Res 51, 2074–2081.
19.Caligiuri, SP, Love, K, Winter, T, et al. (2013) Dietary linoleic acid and α-linolenic acid differentially affect renal oxylipins and phospholipid fatty acids in diet-induced obese rats. J Nutr 143, 1421–1431.
20.Monirujjaman, M, Devassy, JG, Yamaguchi, T, et al. (2017) Distinct oxylipin alterations in diverse models of cystic kidney diseases. Biochim Biophys Acta 1862, 1562–1574.
21.Mendonca, AM, Cayer, LGJ, Pauls, SD, et al. (2018) Distinct effects of dietary ALA, EPA and DHA on rat adipose oxylipins vary by depot location and sex. Prostaglandins Leukot Essent Fatty Acids 129, 13–24.
22.Abeywardena, MY & Charnock, JS (1995) Dietary lipid modification of myocardial eicosanoids following ischemia and reperfusion in the rat. Lipids 30, 1151–1156.
23.Leng, S, Winter, T, Aukema, HM (2017) Dietary LA and sex effects on oxylipin profiles in rat kidney, liver, and serum differ from their effects on PUFAs. J Lipid Res 58, 1702–1712.
24.Leng, S, Winter, T & Aukema, HM (2018) Dietary ALA, EPA and DHA have distinct effects on oxylipin profiles in female and male rat kidney, liver and serum. J Nutr Biochem 57, 228–237.
25.Jun, SS, Chen, Z, Pace, MC, et al. (1998) Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium. J Clin Invest 102, 176–183.
26.Calkin, AC, Sudhir, K, Honisett, S, et al. (2002) Rapid potentiation of endothelium-dependent vasodilation by estradiol in postmenopausal women is mediated via cyclooxygenase 2. J Clin Endocrinol Metab 87, 5072–5075.
27.Hall, LM & Murphy, RC (1998) Electrospray mass spectrometric analysis of 5-hydroperoxy and 5-hydroxyeicosatetraenoic acids generated by lipid peroxidation of red blood cell ghost phospholipids. J Am Soc Mass Spectrom 9, 527–532.
28.Sankaran, D, Lu, J, Bankovic-Calic, N, et al. (2004) Modulation of renal injury in pcy mice by dietary fat containing n-3 fatty acids depends on the level and type of fat. Lipids 39, 207–214.
29.Aukema, HM, Yamaguchi, T, Takahashi, H, et al. (1992) Abnormal lipid and fatty acid compositions of kidneys from mice with polycystic kidney disease. Lipids 27, 429–435.
30.Aukema, HM & Holub, BJ (1989) Effect of dietary supplementation with a fish oil concentrate on the alkenylacyl class of ethanolamine phospholipid in human platelets. J Lipid Res 30, 59–64.
31.Fair, DE, Ogborn, MR, Weiler, HA, et al. (2004) Dietary soy protein attenuates renal disease progression after 1 and 3 weeks in Han:SPRD-cy weanling rats. J Nutr 134, 1504–1507.
32.Wu, S, Chen, W, Murphy, E, et al. (1997) Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes. J Biol Chem 272, 12551–12559.
33.Delozier, TC, Kissling, GE, Coulter, SJ, et al. (2007) Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues. Drug Metab Dispos 35, 682–688.
34.Zhao, G, Wang, J, Xu, X, et al. (2012) Epoxyeicosatrienoic acids protect rat hearts against tumor necrosis factor-α-induced injury. J Lipid Res 53, 456–466.
35.Seubert, JM, Sinal, CJ, Graves, J, et al. (2006) Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function. Circ Res 99, 442–450.
36.Samokhvalov, V, Alsaleh, N, El-Sikhry, HE, et al. (2013) Epoxyeicosatrienoic acids protect cardiac cells during starvation by modulating an autophagic response. Cell Death Dis 4, e885.
37.Igarashi, M, Ma, K, Chang, L, et al. (2008) Rat heart cannot synthesize docosahexaenoic acid from circulating α-linolenic acid because it lacks elongase-2. J Lipid Res 49, 1735–1745.
38.Endo, J, Sano, M, Isobe, Y, et al. (2014) 18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload-induced maladaptive cardiac remodeling. J Exp Med 211, 1673–1687.
39.Arnold, C, Markovic, M, Blossey, K, et al. (2010) Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of (47)-3 fatty acids. J Biol Chem 285, 32720–32733.
40.Li, Y, Kang, JX & Leaf, A (1997) Differential effects of various eicosanoids on the production or prevention of arrhythmias in cultured neonatal rat cardiac myocytes. Prostaglandins 54, 511–530.
41.Keyes, KT, Ye, Y, Lin, Y, et al. (2010) Resolvin E1 protects the rat heart against reperfusion injury. Am J Physiol Heart Circ Physiol 299, H153–H164.
42.Li, X, Hong, S, Li, PL, et al. (2011) Docosahexanoic acid-induced coronary arterial dilation: actions of 17S-hydroxy docosahexanoic acid on K+ channel activity. J Pharmacol Exp Ther 336, 891–899.
43.Westphal, C, Konkel, A & Schunck, WH (2011) CYP-eicosanoids-a new link between omega-3 fatty acids and cardiac disease? Prostaglandins Other Lipid Mediat 96, 99–108.
44.Devassy, JG, Yamaguchi, T, Monirujjaman, M, et al. (2017) Distinct effects of dietary flax compared to fish oil, soy protein compared to casein, and sex on the renal oxylipin profile in models of polycystic kidney disease. Prostaglandins Leukot Essent Fatty Acids 123, 1–13.
45.Ibrahim, NH, Jia, Y, Devassy, JG, et al. (2014) Renal cyclooxygenase and lipoxygenase products are altered in polycystic kidneys and by dietary soy protein and fish oil treatment in the Han:SPRD-Cy rat. Mol Nutr Food Res 58, 768–781.
46.Adams, JW, Migita, DS, Yu, MK, et al. (1996) Prostaglandin F2α stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes. J Biol Chem 271, 1179–1186.
47.Mendez, M & LaPointe, MC (2005) PGE2-induced hypertrophy of cardiac myocytes involves EP4 receptor-dependent activation of p42/44 MAPK and EGFR transactivation. Am J Physiol Heart Circ Physiol 288, H2111–H2117.
48.Moon, SH, Liu, X, Cedars, AM, et al. (2018) Heart failure-induced activation of phospholipase iPLA2γ generates hydroxyeicosatetraenoic acids opening the mitochondrial permeability transition pore. J Biol Chem 293, 115–129.
49.Randriamboavonjy, V, Busse, R & Fleming, I (2003) 20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase. Hypertension 41, 801–806.
50.Cao, J, Singh, SP, McClung, JA, et al. (2017) EET intervention on Wnt1, NOV, and HO-1 signaling prevents obesity-induced cardiomyopathy in obese mice. Am J Physiol Heart Circ Physiol 313, H368–H380.
51.Batchu, SN, Law, E, Brocks, DR, et al. (2009) Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model. J Mol Cell Cardiol 46, 67–74.
52.Harris, WS, Mozaffarian, D, Rimm, E, et al. (2009) Omega-6 fatty acids and risk for cardiovascular disease. Circulation 119, 902–907.
53.Maki, KC, Eren, F, Cassens, ME et al. (2018) ω-6 Polyunsaturated fatty acids and cardiometabolic health: current evidence, controversies, and research gaps. Adv Nutr 9, 688–700.
54.Ramsden, CE, Zamora, D, Majchrzak-Hong, S, et al. (2016) Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968–73). BMJ 353, i1246.
55.Sugiyama, S, Hayakawa, M, Nagai, S, et al. (1987) Leukotoxin, 9, 10-epoxy-12-octadecenoate, causes cardiac failure in dogs. Life Sci 40, 225–231.
56.Edin, ML, Wang, Z, Bradbury, JA, et al. (2011) Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart. FASEB J 25, 3436–3447.
57.Whitaker, MO, Wyche, A, Fitzpatrick, F, et al. (1979) Triene prostaglandins: prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances. Proc Natl Acad Sci U S A 76, 5919–5923.
58.Westwick, J (1976) The effect of pulmonary metabolites of prostaglandins E1, E2 and F2α on ADP-induced aggregation of human and rabbit platelets [proceedings]. Br J Pharmacol 58, 297P–298P.
59.Ikei, KN, Yeung, J, Apopa, PL, et al. (2012) Investigations of human platelet-type 12-lipoxygenase: role of lipoxygenase products in platelet activation. J Lipid Res 53, 2546–2559.
60.Markworth, JF, Kaur, G, Miller, EG, et al. (2016) Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid. The FASEB J 30, 3714–3725.
61.Anggard, E, Larsson, C, Samuelsson, B (1971) The distribution of 15-hydroxy prostaglandin dehydrogenase and prostaglandin-delta 13-reductase in tissues of the swine. Acta Physiol Scand 81, 396–404.
62.Yao, L, Chen, W, Song, K, et al. (2017) 15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury. PLOS ONE 12, e0176106.
63.Myung, S-J, Rerko, RM, Yan, M, et al. (2006) 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis. Proc Natl Acad Sci U S A 103, 12098–12102.
64.Soler, J, Saura, P, Garcia-Lopez, D, et al. (2015) How can linoleic acid be the preferential substrate of the enzyme 15-lipoxygenase-1? A QM/MM approach. J Phys Chem B 120, 1950–1960.
65.Kutzner, L, Goloshchapova, K, Heydeck, D, et al. (2017) Mammalian ALOX15 orthologs exhibit pronounced dual positional specificity with docosahexaenoic acid. Biochim Biophys Acta Mol Cell Biol Lipids 1862, 666–675.
66.Fischer, R, Konkel, A, Mehling, H, et al (2014) Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway. J Lipid Res 55, 1150–1164.
67.Slater-Jefferies, JL, Hoile, SP, Lillycrop, KA et al. (2010) Effect of sex and dietary fat intake on the fatty acid composition of phospholipids and triacylglycerol in rat heart. Prostaglandins Leukot Essent Fatty Acids 83, 219–223.
68.Kitson, AP, Smith, TL, Marks, KA et al. (2012) Tissue-specific sex differences in docosahexaenoic acid and Δ6-desaturase in rats fed a standard chow diet. Appl Physiol Nutr Metab 37, 1200–1211.
69.Zhou, Y, Lin, S, Chang, H-H, et al. (2005) Gender differences of renal CYP-derived eicosanoid synthesis in rats fed a high-fat diet. American journal of hypertension 18, 530–537.
70.Geary, GG, Krause, DN, Duckles, SP (2000) Estrogen reduces mouse cerebral artery tone through endothelial NOS- and cyclooxygenase-dependent mechanisms. Am J Physiol Heart Circ Physiol 279, H511–H519.
71.Pergola, C, Rogge, A, Dodt, G, et al. (2011) Testosterone suppresses phospholipase D, causing sex differences in leukotriene biosynthesis in human monocytes. FASEB J 25, 3377–3387.
72.Zuniga-Munoz, AM, Guarner Lans, V, Soria-Castro, E, et al. (2015) 17β estradiol modulates perfusion pressure and expression of 5-LOX and CYP450 4A in the isolated kidney of metabolic syndrome female rats. Int J Endocrinol, 149408.
73.Holla, VR, Adas, F, Imig, JD, et al. (2001) Alterations in the regulation of androgen-sensitive Cyp 4A monooxygenases cause hypertension. Proc Natl Acad Sci U S A 98, 5211–5216.
74.O’Donnell, VB, Murphy, RC (2012) New families of bioactive oxidized phospholipids generated by immune cells: identification and signaling actions. Blood 120, 1985–1992.
75.Slatter, DA, Percy, CL, Allen-Redpath, K, et al. (2018) Enzymatically oxidized phospholipids restore thrombin generation in coagulation factor deficiencies. JCI Insight 3, pii 98459.
76.Schebb, NH, Ostermann, AI, Yang, J, et al. (2014) Comparison of the effects of long-chain omega-3 fatty acid supplementation on plasma levels of free and esterified oxylipins. Prostaglandins Other Lipid Mediat 113–115, 21–29.